Sevil Kamalı

3.1k total citations
72 papers, 1.7k citations indexed

About

Sevil Kamalı is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sevil Kamalı has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Rheumatology, 30 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Sevil Kamalı's work include Vasculitis and related conditions (27 papers), Systemic Lupus Erythematosus Research (15 papers) and Ocular Diseases and Behçet’s Syndrome (10 papers). Sevil Kamalı is often cited by papers focused on Vasculitis and related conditions (27 papers), Systemic Lupus Erythematosus Research (15 papers) and Ocular Diseases and Behçet’s Syndrome (10 papers). Sevil Kamalı collaborates with scholars based in Türkiye, United States and United Kingdom. Sevil Kamalı's co-authors include Murat İnanç, Ahmet Gül, Orhan Aral, Shahid Jameel, Mohammad Sultan Khuroo, Lale Öçal, Meral Koniçe, Esen Kasapoğlu Günal, Ayşe Çefle and Mehmet Sayarlıoğlu and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Investigative Ophthalmology & Visual Science.

In The Last Decade

Sevil Kamalı

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevil Kamalı Türkiye 21 790 453 415 284 260 72 1.7k
Jean Charles Piette France 32 1.1k 1.3× 574 1.3× 330 0.8× 231 0.8× 137 0.5× 84 2.5k
Syuji Takei Japan 26 1.2k 1.5× 473 1.0× 750 1.8× 196 0.7× 424 1.6× 108 2.7k
J.C. Pietté France 25 979 1.2× 527 1.2× 227 0.5× 353 1.2× 116 0.4× 140 2.2k
F. Domont France 16 403 0.5× 405 0.9× 236 0.6× 266 0.9× 132 0.5× 34 1.2k
Karim Sacré France 26 881 1.1× 531 1.2× 620 1.5× 128 0.5× 166 0.6× 116 2.1k
Achille Aouba France 30 1.2k 1.6× 1.4k 3.1× 433 1.0× 110 0.4× 385 1.5× 157 2.8k
Cloé Comarmond France 26 853 1.1× 1.1k 2.5× 446 1.1× 222 0.8× 176 0.7× 59 2.5k
Nancy B. Allen United States 28 1.1k 1.5× 1.3k 3.0× 334 0.8× 144 0.5× 231 0.9× 53 2.5k
Karyl S. Barron United States 26 732 0.9× 481 1.1× 978 2.4× 217 0.8× 1.1k 4.0× 56 2.6k
Léa Savey France 15 288 0.4× 330 0.7× 369 0.9× 60 0.2× 263 1.0× 50 1.1k

Countries citing papers authored by Sevil Kamalı

Since Specialization
Citations

This map shows the geographic impact of Sevil Kamalı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevil Kamalı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevil Kamalı more than expected).

Fields of papers citing papers by Sevil Kamalı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevil Kamalı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevil Kamalı. The network helps show where Sevil Kamalı may publish in the future.

Co-authorship network of co-authors of Sevil Kamalı

This figure shows the co-authorship network connecting the top 25 collaborators of Sevil Kamalı. A scholar is included among the top collaborators of Sevil Kamalı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevil Kamalı. Sevil Kamalı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamalı, Sevil, et al.. (2023). B.4 Quantitative electroencephalography to predict post-stroke disability: a systematic review and meta-analysis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50(s2). S51–S51. 1 indexed citations
2.
Omma, Ahmet, Abdülsamet Erden, Ayten Yazıcı, et al.. (2022). Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritis. International Journal of Rheumatic Diseases. 25(7). 775–780. 4 indexed citations
3.
Kamalı, Sevil, Fatma Savran Oğuz, Bahar Artım-Esen, et al.. (2021). A shared motif of hla-dpb1 affecting the susceptibility to pr3-anca positive granulomatosis with polyangiitis: comparative analysis of a Turkish cohort with matched healthy controls. Rheumatology International. 41(9). 1667–1672. 4 indexed citations
4.
Aydın, Sibel Zehra, Salih Pay, Nevsun İnanç, et al.. (2017). Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience.. PubMed. 35(3). 508–511. 5 indexed citations
5.
Omma, Ahmet, Burak Erer, Ömer Karadağ, et al.. (2017). Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort.. PubMed. 35 Suppl 103(1). 77–82. 14 indexed citations
6.
Kanıtez, Nilüfer Alpay, Mine Güllüoğlu, Burak Erer, et al.. (2016). Microscopic colitis in patients with Takayasu’s arteritis: a potential association between the two disease entities. Clinical Rheumatology. 35(10). 2495–2499. 8 indexed citations
7.
Pay, Salih, Nevsun İnanç, Sevil Kamalı, et al.. (2014). Use of musculoskeletal ultrasound in rheumatoid arthritis in Turkey among rheumatologists: A national targeted ultrasound initiative survey. European Journal of Rheumatology. 2(1). 43–44. 5 indexed citations
8.
Dalkılıç, Ediz, et al.. (2011). Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases. Modern Rheumatology. 22(3). 463–466. 4 indexed citations
9.
Aydın, Sibel Zehra, Neslihan Yılmaz, Servet Akar, et al.. (2010). Assessment of disease activity and progression in Takayasu’s arteritis with Disease Extent Index-Takayasu. Lara D. Veeken. 49(10). 1889–1893. 90 indexed citations
10.
Sayarlıoğlu, Mehmet, Murat İnanç, Sevil Kamalı, et al.. (2010). Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatology International. 32(1). 177–182. 59 indexed citations
11.
Çefle, Ayşe, Murat İnanç, Mehmet Sayarlıoğlu, et al.. (2009). Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatology International. 31(2). 183–189. 47 indexed citations
12.
Günal, Esen Kasapoğlu, Sevil Kamalı, Lale Öçal, et al.. (2009). Rosai–Dorfman disease with factor XII deficiency. Clinical Rheumatology. 28(6). 733–736. 4 indexed citations
13.
Erer, Burak, Sevil Kamalı, İşın Kiliçaslan, et al.. (2009). Recurrent anterior uveitis in Henoch Schonlein’s vasculitis. Rheumatology International. 30(10). 1377–1379. 2 indexed citations
14.
Günal, Esen Kasapoğlu, Sevil Kamalı, Ahmet Gül, et al.. (2008). Clinical evaluation and comparison of different criteria for classification in Turkish patients with psoriatic arthritis. Rheumatology International. 28(10). 959–964. 3 indexed citations
15.
İnanç, Nevsun, Ediz Dalkılıç, Sevil Kamalı, et al.. (2006). Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clinical Rheumatology. 26(1). 17–23. 69 indexed citations
16.
Boura, Panagiota, et al.. (2006). Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet Disease (ABD). Neurological Sciences. 27(6). 432–435. 3 indexed citations
17.
Tuğal-Tutkun, İlknur, Abdulbaki Mudun, Meri Urgancıoğlu, et al.. (2005). Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in behçet's disease: An open‐label trial. Arthritis & Rheumatism. 52(8). 2478–2484. 222 indexed citations
18.
Tuğal-Tutkun, İlknur, Ahmet Gül, Abdulbaki Mudun, et al.. (2004). Efficacy of Infliximab in the Treatment of Uveitis Resistant to the Combination of Azathioprine and Cyclosporin in Behçet's Disease: Preliminary Report of an Open Trial. Investigative Ophthalmology & Visual Science. 45(13). 2670–2670. 1 indexed citations
19.
Kamalı, Sevil, Murat İnanç, Ahmet Gül, et al.. (2004). Systemic necrotizing vasculitides in Turkey: a comparative analysis of 40 consecutive patients. Rheumatology International. 26(1). 16–20. 6 indexed citations
20.
Kamalı, Sevil, Ayşe Çefle, Mehmet Sayarlıoğlu, et al.. (2004). Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases. Rheumatology International. 25(3). 211–214. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026